perimenopause and glp 1 A thoughtful approach to GLP-1 therapy, especially during perimenopause. These results are just 3.5 months apart! At baseline, this patient was already at a healthy weight. The goal was not drastic weight The GLP-1/GIP dual-receptor agonist tirzepatide

Uncovering the characteristics of the gut microbiota in patients with ischemic stroke and hemorrhagic stroke

Unlike GHRP-6 and GHRP-2, ipamorelin does not elevate plasma cortisol or ACTH at growth hormone-releasing doses

What is the standard KLOW peptide dosage

Additionally, the presence of emerging pharmaceutical companies and increased foreign direct investments contributes to market dynamism

Chemistry Today's November-December 2025 review of peptide synthesis advances explicitly identified "fully aqueous synthesis" and "integration of artificial intelligence to streamline manufacturing processes" as future directions for the field